Back

StatPearls, LLC

  • Antibodies, Anti-Idiotypic
  • Immunoglobulin G
  • Immunoglobulin M
  • Purpura, Thrombocytopenic, Idiopathic
  • Transfusion Reaction

Type II Hypersensitivity Reaction

Type II hypersensitivity reactions, also known as antibody-mediated cytotoxic reactions, involve immune responses in which immunoglobulin G or immunoglobulin M antibodies bind to antigens on the surface of host cells, leading to complement activation, opsonization, and subsequent cellular destruction. These reactions underlie several clinically significant disorders, including autoimmune hemolytic anemia, transfusion reactions, hemolytic disease of the newborn, and immune thrombocytopenia. The pathophysiologic process results from the immune system s misrecognition of self-antigens, producing targeted cell lysis and tissue injury. Clinical manifestations depend on the affected cell type, ranging from anemia and jaundice to bleeding tendencies or organ-specific dysfunction. Diagnostic evaluation relies on serologic testing, direct antiglobulin (Coombs) testing, and analysis of blood smears or hemolysis markers. Prompt recognition and management through withdrawal of the triggering agent, administration of corticosteroids or immunosuppressive therapy, and supportive care are essential to prevent complications and preserve hematologic stability. The participant develops advanced competence in recognizing the mechanisms, clinical presentations, and diagnostic criteria of type II hypersensitivity reactions while integrating evidence-based approaches to treatment. The course strengthens the clinician s ability to differentiate antibody-mediated cytotoxicity from other hypersensitivity types and implement timely interventions that reduce morbidity and improve patient safety. Interprofessional collaboration among clinicians, nurses, pharmacists, and laboratory specialists ensures accurate diagnosis, coordinated treatment, and effective monitoring of therapeutic response. Nursing staff contribute through vigilant assessment for transfusion reactions and patient education, pharmacists ensure medication safety and dosing adjustments for immunosuppressive therapies, and…

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 2 creditsAAPA Category 1 Credit™Up to 2 creditsAMA PRA Category 1 Credit™Up to 2 creditsNursingUp to 2 creditsPharmacyUp to 2 credits

MOC types

ABS — Accredited CMEUp to 2 pointsABPATH — Lifelong LearningUp to 2 pointsABA — Lifelong LearningUp to 2 pointsABTS — Accredited CMEUp to 2 pointsABIM — Medical KnowledgeUp to 2 pointsABS — Self-AssessmentUp to 2 pointsABP — Lifelong Learning and Self-AssessmentUp to 2 pointsABOHNS — Self-AssessmentUp to 2 pointsABTS — Self-AssessmentUp to 2 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 9 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 2 credits
  • MOC · Up to 2 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left